OpGen, Inc. (OTC:OPGN – Get Free Report) passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $1.77 and traded as high as $7.50. OpGen shares last traded at $6.40, with a volume of 27,677 shares trading hands.
OpGen Stock Up 17.2%
The firm has a market capitalization of $75.53 million, a P/E ratio of -1.35 and a beta of -1.77. The firm has a 50 day moving average of $1.92 and a 200-day moving average of $3.35.
OpGen Company Profile
OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.
Featured Articles
- Five stocks we like better than OpGen
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Meta Platforms May Ditch NVIDIA Chips—Here’s Why Investors Care
- High Dividend REITs: Are They an Ideal Way to Diversify?
- SoFi Technologies: From Fintech Speculation to Profit Engine
- Stock Dividend Cuts Happen Are You Ready?
- Gold to $5,000? What Bank of America and UBS Have to Say
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
